(AXSM) is $ The current on short-term price targets is based on 11 reports. What is Axsome Therapeutics, Inc.'s forecast for ? Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system . Discover real-time Axsome Therapeutics, Inc. Common Stock (AXSM) stock prices, quotes, historical data, news, and Insights for informed trading and. Axsome Therapeutics Inc. ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Find the latest analyst research, reports, and ratings for Axsome Therapeutics, Inc. Common Stock (AXSM) at cryptoairdrops.ru
The intrinsic value of one AXSM stock under the Base Case scenario is USD. Compared to the current market price of USD, Axsome Therapeutics Inc is. After Hours: $ (%) ; Intra-Cellular Therapies Inc. $ ITCI % ; Intellia Therapeutics Inc. $ NTLA % ; Viking Therapeutics Inc. Axsome's stock rallies 15% on promising findings for its experimental Alzheimer's drug. Shares of Axsome Therapeutics Inc. jumped % in premarket trading. View Axsome Therapeutics, Inc AXSM investment & stock information. Get the latest Axsome Therapeutics, Inc AXSM detailed stock quotes, stock data. The latest closing stock price for Axsome Therapeutics as of September 06, is · The all-time high Axsome Therapeutics stock closing price was The current price of AXSM is USD — it has decreased by −% in the past 24 hours. Watch Axsome Therapeutics, Inc. stock price performance more closely. The average price target for Axsome Therapeutics Inc is $ This is based on 15 Wall Streets Analysts month price targets, issued in the past 3 months. Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous. Axsome Therapeutics has a consensus price target of $ Q. What is the current price for Axsome Therapeutics (AXSM)?. On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $ by Sep 6, The average Axsome Therapeutics stock price.
Axsome Therapeutics Inc (AXSM) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Axsome focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia. Get Axsome Therapeutics Inc (AXSM.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change The latest Axsome Therapeutics stock prices, stock quotes, news, and AXSM history to help you invest and trade smarter. Company has been rated SELL since 11/20/ The Company's Fundamentals Look Very Poor Making an Investment in Its Shares Purely Speculative. View Axsome Therapeutics, Inc. AXSM stock quote prices, financial information, real-time forecasts, and company news from CNN. Track Axsome Therapeutics Inc (AXSM) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Axsome Therapeutics Inc. · AFTER HOURS PM EDT 09/04/24 · % · AFTER HOURS Vol 7, 36 minutes ago. AXSM - Axsome Therapeutics, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGM). Axsome Therapeutics, Inc. (cryptoairdrops.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Axsome Therapeutics. See AXSM stock price and Buy/Sell Axsome Therapeutics. Discuss news and analysts' price predictions with the investor community.
Medaro Mining Stock Forecast | Where To Start When Buying Stocks